Attention-Deficit/Hyperactivity disorder in a chronic care Paradigm

Postgraduate Medicine

Volumn 125, Issue 4, 2013, Pages 78-86

  Culpepper, Larry ^a   Fried, Ronna ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Attention deficit hyperactivity disorder; Chronic care models; Integrated health care team; Life span disorder; Primary care physician

Indexed keywords

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CHRONIC DISEASE; COMMUNITY CARE; DECISION SUPPORT SYSTEM; HUMAN; INTEGRATED HEALTH CARE SYSTEM; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PRIMARY HEALTH CARE; SELF CARE; UNITED STATES;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHRONIC DISEASE; COMMUNITY HEALTH SERVICES; DECISION SUPPORT TECHNIQUES; DELIVERY OF HEALTH CARE, INTEGRATED; HUMANS; PATIENT CARE TEAM; PRIMARY HEALTH CARE; SELF CARE; UNITED STATES;

EID: 84885920647     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2013.07.2680     Document Type: Article

References (89)

1. Lahey BB, Applegate B, McBurnett K,. DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents. Am J Psychiatry. 1994;151(11):1673-1685
2. Primich C, Iennaco J. Diagnosing adult attention-deficit hyperactivity disorder: the importance of establishing daily life contexts for symptoms and impairments. J Psychiatr Ment Health Nurs. 2012;19(4):362-373
3. Kessler RC, Green JG, Adler LA,. Structure and diagnosis of adult attention-deficit/hyperactivity disorder: analysis of expanded symptom criteria from the Adult ADHD Clinical Diagnostic Scale. Arch Gen Psychiatry. 2010;67(11):1168-1178
4. Bolea B, Adamou M, Arif M,. ADHD matures: time for practitioners to do the same? J Psychopharmacol. 2012;26(6):766-770
5. Kooij SJ, Bejerot S, Blackwell A,. European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry. 2010;10:67
6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Washington, DC: American Psychiatric Association; 2013
7. Simon V, Czobor P, Bálint S, Mészáros A, Bitter I. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry. 2009;194(3):204-211
8. Kessler RC, Adler L, Barkley R,. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716-723
9. Fayyad J, De Graaf R, Kessler R,. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry. 2007;190:402-409
10. Lesch KP, Timmesfeld N, Renner TJ,. Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. J Neural Transm. 2008;115(11):1573-1585
11. Archer T, Oscar-Berman M, Blum K. Epigenetics in developmental disorder: ADHD and endophenotypes. J Genet Syndr Gene Ther. 2011;2(104):1000104
12. Gustafsson P, Källén K. Perinatal, maternal, and fetal characteristics of children diagnosed with attention-deficit-hyperactivity disorder: results from a population-based study utilizing the Swedish Medical Birth Register. Dev Med Child Neurol. 2011;53(3):263-268
13. Rietveld MJ, Hudziak JJ, Bartels M, van Beijsterveldt CE, Boomsma DI. Heritability of attention problems in children: longitudinal results from a study of twins, age 3 to 12. J Child Psychol Psychiatry. 2004;45 (3):577-588
14. Saviouk V, Hottenga JJ, Slagboom EP,. ADHD in Dutch adults: heritability and linkage study. Am J Med Genet B Neuropsychiatr Genet. 2011;156B(3):352-362
15. Biederman J. Attention-deficit/hyperactivity disorder: a selective overview. Biol Psychiatry. 2005;57(11):1215-1220
16. Boomsma DI, Saviouk V, Hottenga JJ,. Genetic epidemiology of attention deficit hyperactivity disorder (ADHD index) in adults. PLoS One. 2010;5(5):e10621
17. Xu X, Mill J, Sun B,. Association study of promoter polymorphisms at the dopamine transporter gene in Attention Deficit Hyperactivity Disorder. BMC Psychiatry. 2009;9:3
18. Karama S, Grizenko N, Sonuga-Barke E,. Dopamine transporter 3′UTR VNTR genotype is a marker of performance on executive function tasks in children with ADHD. BMC Psychiatry. 2008;8:45
19. Li D, Sham PC, Owen MJ, He L. Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Hum Mol Genet. 2006;15(14):2276-2284
20. Cuffe SP, Moore CG, McKeown R. ADHD and health services utilization in the national health interview survey. J Atten Disord. 2009;12(4):330-340
21. Kent KM, Pelham WE Jr, Molina BS,. The academic experience of male high school students with ADHD. J Abnorm Child Psychol. 2011;39(3):451-462
22. Fried R, Petty CR, Surman CB,. Characterizing impaired driving in adults with attention-deficit/hyperactivity disorder: a controlled study. J Clin Psychiatry. 2006;67(4):567-574
23. Goodman DW. The consequences of attention-deficit/hyperactivity disorder in adults. JPsychiatr Pract. 2007;13(5):318-327
24. Torgersen T, Gjervan B, Rasmussen K. ADHD in adults: a study of clinical characteristics, impairment and comorbidity. Nord J Psychiatry. 2006;60(1):38-43
25. Hosain GM, Berenson AB, Tennen H, Bauer LO, Wu ZH. Attention deficit hyperactivity symptoms and risky sexual behavior in young adult women. J Womens Health (Larchmt). 2012;21(4):463-468
26. Das D, Cherbuin N, Butterworth P, Anstey KJ, Easteal S. A population-based study of attention deficit/hyperactivity disorder symptoms and associated impairment in middle-aged adults. PLoS One. 2012;7(2):e31500
27. Moyá J, Stringaris AK, Asherson P, Sandberg S, Taylor E. The impact of persisting hyperactivity on social relationships: a community-based, controlled 20-year follow-up study [published online ahead of print March 21, 2012]. J Atten Disord
28. Lichtenstein P, Halldner L, Zetterqvist J,. Medication for attention deficit-hyperactivity disorder and criminality. N Engl J Med. 2012;367(21):2006-2014
29. Sibley MH, Pelham WE, Molina BS,. When diagnosing ADHD in young adults emphasize informant reports, DSM items, and impairment. J Consult Clin Psychol. 2012;80(6):1052-1061
30. Faraone SV, Kunwar A, Adamson J, Biederman J. Personality traits among ADHD adults: implications of late-onset and subthreshold diagnoses. Psychol Med. 2009;39(4):685-693
31. Wolraich M, Brown L, Brown RT,; Subcommittee on Attention-Deficit/Hyperactivity Disorder; Steering Committee on Quality Improvement and Management. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011;128(5):1007-1022
32. Bates K, Bartoshesky L, Friedland A. As the child with chronic disease grows up: transitioning adolescents with special health care needs to adult-centered health care. Del Med J. 2003;75(6):217-220
33. Katon WJ, Lin EH, Von Korff M,. Collaborative care for patients with depression and chronic illnesses. N Engl J Med. 2010;363(27):2611-2620
34. Maiers MJ, Westrom KK, Legendre CG, Bronfort G. Integrative care for the management of low back pain: use of a clinical care pathway. BMC Health Serv Res. 2010;10:298
35. Tapp H, Phillips SE, Waxman D, Alexander M, Brown R, Hall M. Multidisciplinary team approach to improved chronic care management for diabetic patients in an urban safety net ambulatory care clinic. J Am Board Fam Med. 2012;25(2):245-246
36. Hinnenthal JA, Perwien AR, Sterling KL. A comparison of service use and costs among adults with ADHD and adults with other chronic diseases. Psychiatr Serv. 2005;56(12):1593-1599
37. Lorig KR, Ritter P, Stewart AL,. Chronic disease self-management program: 2-year health status and health care utilization outcomes. Med Care. 2001;39(11):1217-1223
38. Bernstein J. The elusive benefits of chronic care management: comment on “the effect of guided care teams on the use of health services”. Arch Intern Med. 2011;171(5):466-467
39. Bodenheimer T, Chen E, Bennett HD. Confronting the growing burden of chronic disease: can the U.S. health care workforce do the job? Health Aff (Millwood). 2009;28(1):64-74
40. Hodgkins P, Montejano L, Sasané R, Huse D. Cost of illness and comorbidities in adults diagnosed with attention-deficit/hyperactivity disorder: a retrospective analysis. Prim Care Companion CNS Disord. 2011;13(2):PCC10m01030
41. Faraone SV, Biederman J, Doyle A,. Neuropsychological studies of late onset and subthreshold diagnoses of adult attention-deficit/hyperactivity disorder. Biol Psychiatry. 2006;60:1081-1087
42. Culpepper L, Mattingly G. Challenges in identifying and managing attention-deficit/hyperactivity disorder in adults in the primary care setting: a review of the literature. Prim Care Companion J Clin Psychiatry. 2010;12(6):PCC10r00951
43. Kessler RC, Adler LA, Gruber MJ, Sarawate CA, Spencer T, Van Brunt DL. Validity of the World Health Organization Adult ADHD Self-Report Scale (ASRS) Screener in a representative sample of health plan members. Int J Methods Psychiatr Res. 2007;16(2):52-65
44. Barkley RA. Barkley Adult ADHD Rating Scale-IV(BAARS-IV). New York, NY: Guilford Press; 2011
45. Conners CK, Erhardt D, Epstein JN, Parker JDA, Sitarenios G, Sparrow E. Self-ratings of ADHD symptoms in adults I: factor structure and normative data. J Atten Disord. 1999;3(3):141-151
46. Gomez R. Item response theory analyses of adult self-ratings of the ADHD symptoms in the Current Symptoms Scale. Assessment. 2011;18(4):476-486
47. Ward MF, Wender PH, Reimherr FW. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry. 1993;150(6):885-890
48. ADHD Current Symptoms Scale. http://www.mnadhd.com/Current_Symptoms_Scale_self.pdf. Accessed August 3, 2012
49. Adult ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist. http://www.hcp.med.harvard.edu/ncs/ftpdir/adhd/18%20Question%20ADHD-ASRS-v1-1.pdf. Accessed August 3, 2012
50. Rosier M, Retz W, Thome J, Schneider M, Stieglitz RD, Falkai P. Psychopathological rating scales for diagnostic use in adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci. 2006;256(suppl 1):i3-i11
51. Seixas M, Weiss M, Müller U. Systematic review of national and international guidelines on attention-deficit hyperactivity disorder. J Psychopharmacol. 2011;26(6):753-765
52. Rostain AL. Attention-deficit/hyperactivity disorder in adults: evidence-based recommendations for management. Postgrad Med. 2008;120(3):27-38
53. Rosier M, Casas M, Konofal E, Buitelaar J. Attention deficit hyperactivity disorder in adults. World J Biol Psychiatry. 2010;11:684-698
54. Safren SA, Duran P, Yovel I, Perlman CA, Sprich S. Medication adherence in psychopharmacologically treated adults with ADHD. J Atten Disord. 2007;10(3):257-260
55. Adler LD, Nierenberg AA. Review of medication adherence in children and adults with ADHD. Postgrad Med. 2010;122(1):184-191
56. Caisley H, Müller U. Adherence to medication in adults with attention deficit hyperactivity disorder and pro re nata dosing of psychostimulants: a systematic review. Eur Psychiatry. 2012;27(5):343-349
57. Goodman DW, Lasser RA, Babcock T, Pucci ML, Solanto MY. Managing ADHD across the lifespan in the primary care setting. Postgrad Med. 2011;123(5):14-26
58. Murphy K, Ratey N, Maynard S, Sussman S, Wright SD. Coaching for ADHD. J Atten Disord. 2010;13(5):546-552
59. Harwood TM, Pratt D, Beutler LE, Bongar BM, Lenore S, Forrester BT. Technology, telehealth, treatment enhancement, and selection. Prof Psychol Res Pract. 2011;42(6):448-454
60. Barnett JE. Utilizing technological innovations to enhance psychotherapy supervision, training, and outcomes. Psychotherapy (Chic). 2011;48(2):103-108
61. Szczesna A, Tomaszek M, Wieteska A. The methodology of designing serious games for children and adolescents focused on psychological goals. Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). Vol 7339 LNBI. Gliwice, Poland; 2012:245-255
62. Volner R, Tichá D, Palásthy H. Computer-based cognitive and socioemotional training in personal health information management. Presented at: Proceedings—International Carnahan Conference on Security Technology, 2011; Barcelona
63. Greene J, Rogers VW, Yedidia MJ. The impact of implementing a chronic care residency training initiative on asthma outcomes. Acad Med. 2007;82(2):161-167
64. Yu GC, Beresford R. Implementation of a chronic illness model for diabetes care in a family medicine residency program. J Gen Intern Med. 2010;25(suppl 4):S615-S619
65. Sanchez I. Implementation of a diabetes self-management education program in primary care for adults using shared medical appointments. Diabetes Educ. 2011;37(3):381-391
66. Adair R, Christianson J, Wholey DR,. Care guides: employing nonclinical laypersons to help primary care teams manage chronic disease. J Ambul Care Manage. 2012;35(1):27-37
67. Landon BE, Hicks LS, O'Malley AJ,. Improving the management of chronic disease at community health centers. N Engl J Med. 2007;356(9):921-934
68. Attention Deficit Disorder Association. Finding help and support, http://www.add.org/7page=finding_help_support. Accessed May 24, 2012
69. Weiss MD, Weiss JR. A guide to the treatment of adults with ADHD. J Clin Psychiatry. 2004;65(suppl 3):27-37
70. Hinojosa MS, Fernandez-Baca D, Knapp C. Factors associated with family-provider partnership among children with ADHD. Fam Med. 2012;44(7):463-470
71. Wagner EH. The role of patient care teams in chronic disease management. BMJ. 2000;320(7234):569-572
72. Duncan I, Ahmed T, Li QE,. Assessing the value of the diabetes educator. Diabetes Educ. 2011;37(5):638-657
73. Molenaar EA, van Ameijden EJ, Vergouwe Y, Grobbee DE, Numans ME. Effect of nutritional counselling and nutritional plus exercise counselling in overweight adults: a randomized trial in multidisciplinary primary care practice. Fam Pract. 2010;27(2):143-150
74. Lin EH, Von Korff M, Ciechanowski P,. Treatment adjustment and medication adherence for complex patients with diabetes, heart disease, and depression: a randomized controlled trial. Ann Fam Med. 2012;10(1):6-14
75. Bogner HR, Morales KH, de Vries HF, Cappola AR. Integrated management of type 2 diabetes mellitus and depression treatment to improve medication adherence: a randomized controlled trial. Ann Fam Med. 2012;10(1):15-22
76. McCall N, Cromwell J. Results of the Medicare Health Support disease-management pilot program. N Engl J Med. 2011;365(18):1704-1712
77. Brown TE, Brams M, Gao J, Gasior M, Childress A. Open-label administration of lisdexamfetamine dimesylate improves executive function impairments and symptoms of attention-deficit/hyperactivity disorder in adults. Postgrad Med. 2010;122(5):7-17
78. Brown TE, Holdnack J, Saylor K,. Effect of atomoxetine on executive function impairments in adults with ADHD. J Atten Disord. 2011;15(2):130-138
79. Biederman J, Mick E, Faraone SV. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry. 2000;157(5):816-818
80. Newcorn JH. Age-related considerations in the treatment of ADHD. CNS Spectr. 2007;12(suppl 23):10-13
81. Kubik JA. Efficacy of ADHD coaching for adults with ADHD. J Atten Disord. 2010;13(5):442-453
82. Bonomi AE, Wagner EH, Glasgow RE, VonKorff M. Assessment of chronic illness care (ACIC): a practical tool to measure quality improvement. Health Serv Res. 2002;37(3):791-820
83. Jhaveri M, Lee E. Performance of electronic diaries in diabetes clinical trials measured through overall satisfaction of site coordinators. J Diabetes Sci Technol. 2007;1(4):522-530
84. Janssen M, Portalatin M, Wallace J, Zhong W, Parkes JL. Ascensia WinGLUCOFACTS Professional Software improves diabetes health outcomes. J Diabetes Sci Technol. 2007;1(1):47-53
85. Turgay A, Goodman DW, Asherson P,. Lifespan persistence of ADHD: the life transition model and its application. J Clin Psychiatry. 2012;73(2):192-201
86. Toomey SL, Chan E, Ratner JA, Schuster MA. The patient-centered medical home, practice patterns, and functional outcomes for children with attention deficit/hyperactivity disorder. Acad Pediatr. 2011;11(6):500-507
87. Brod M, Pohlman B, Lasser R, Hodgkins P. Comparison of the burden of illness for adults with ADHD across seven countries: a qualitative study. Health Qual Life Outcomes. 2012;10(1):47
88. Kessler RC, Lane M, Stang PE, Van Brunt DL. The prevalence and workplace costs of adult attention deficit hyperactivity disorder in a large manufacturing firm. Psychol Med. 2009;39(1):137-147
89. Ohlmeier MD, Goseberg E, Roy M, Dillo W, Kordon A, Prox-Vagedes V. Alcohol and drug dependence in adults with attention-deficit/hyperactivity disorder: data from Germany. Eur J Psychiatry. 2011;25(3):150-163